Debra Zack
Nessuna posizione attualmente
Patrimonio netto: 174 135 $ in data 31/03/2024
Profilo
Debra Jeske Zack worked as an Executive Director-Global Product Area at Amgen, Inc. and as a Vice President-Clinical Development at Xencor, Inc. Prior to that, she was an Associate Professor at the University of California, Los Angeles.
She also served as the Chief Medical Officer at Exagen, Inc. from 2020 to 2022.
Dr. Zack received her undergraduate degree from Texas Christian University and her doctorate from The University of Texas Southwestern Medical Center.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
EXAGEN, INC.
0.64% | 18/04/2023 | 109 519 ( 0.64% ) | 174 135 $ | 31/03/2024 |
Precedenti posizioni note di Debra Zack
Società | Posizione | Fine |
---|---|---|
EXAGEN INC. | Chief Tech/Sci/R&D Officer | 05/12/2022 |
University of California, Los Angeles | Corporate Officer/Principal | - |
AMGEN INC. | Corporate Officer/Principal | - |
XENCOR, INC. | Corporate Officer/Principal | - |
Formazione di Debra Zack
Texas Christian University | Undergraduate Degree |
The University of Texas Southwestern Medical Center | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
AMGEN INC. | Health Technology |
XENCOR, INC. | Health Technology |
EXAGEN INC. | Health Services |
- Borsa valori
- Insiders
- Debra Zack